Piotrowska, Z., Tan, D. S., Smit, E. F., Spira, A. I., Soo, R. A., Nguyen, D., Lee, V. H., Yang, J. C., Velcheti, V., Wrangle, J. M., Socinski, M. A., Koczywas, M., Janik, J. E., Jones, J., Yu, H. A. (2026). Erratum: Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01931